GSK-951

N/A

Report date: 2025/03/21 08:53:15
NME

Base Information

Drug NameGSK-951
Drug Alias NameGSK-951
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKallikrein-5 inhibitors
TargetsKallikrein-5
Therapy Area/IndicationsNetherton Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsNetherton Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A